|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1 CAD | 0.00% |
|
0.00% | -44.44% |
| Apr. 25 | Transcript : Valeo Pharma Inc. - Shareholder/Analyst Call | |
| Mar. 22 | Valeo Pharma Inc. Announces Appointment of Al Moghaddam to Board of Directors | CI |
Valeo Pharma Inc. provided earnings guidance for the year 2023. The company expects revenues to continue to grow this year with a target revenue base of $60-plus million.
| 1st Jan change | Capi. | |
|---|---|---|
| -44.44% | 7.25M | |
| +31.37% | 595B | |
| -2.60% | 367B | |
| +20.83% | 334B | |
| +5.69% | 289B | |
| +14.83% | 239B | |
| +9.93% | 211B | |
| -6.95% | 203B | |
| +10.77% | 171B | |
| +0.10% | 163B |
VALEO PHARMA INC. 